Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6641-6649

  Blömer, Ulrike ^a   Naldini, Luigi ^a,b   Kafri, Tal ^a   Trono, Didier ^a   Verma, Inder M ^a   Gage, Fred H ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b CELL GENESYS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE TRANSFER; LENTIVIRINAE; MOLONEY LEUKEMIA ONCOVIRUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENE;

EID: 1842411367     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.6641-6649.1997     Document Type: Article

References (71)

1. Afione, S. A., C. K. Conrad, W. G. Kearns, S. Chunduru, R. Adams, T. C. Reynolds, W. B. Gugglno, G. R. Cutting, B. J. Carter, and T. R. Flotte. 1996. In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70:3235-3241.
2. Akli, S., C. Caillaud, E. Vigne, L. D. Stratford-Perricaudet, L. Poenaru, M. Perricaudet, A. Kahn, and M. R. Peschanski. 1993, Transfer of a foreign gene into the brain using adenovirus vectors. Nat. Genet. 3:224-228.
3. Bajocchi, G., S. H. Feldman, R. G. Crystal, and A. Mastrangeli. 1993. Direct in vivo gene transfer to ependymal cells in the central nervous system using rccomhinant adenovirus vectors. Nat. Genet. 3:229-234.
4. Baskar, J. F., P. P. Smith, G. Nilaver, R. A. Jupp, S. Hoffmann, N. J. Peffer, D. J. Tenney, A. M. Colberg-Poley, P. Ghazal, and J. A. Nelson. 1996. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgcnic mice. J. Virol. 70:3207-3214.
5. Berns, K. I., and R. M. Linden. 1995. The cryptic life style of adenoassocialed virus. Bioessays 17:237-245.
6. Bishop, J. M., and H. Varmus. 1984. Functions and origins of retroviral transforming genes: RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
7. Brubaker, J. O., C. M. Thompson, L. A. Morrison, D. M. Knipe, G. R. Siber, and R. W. Finberg. 1996. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus. J. Immunol. 157:1598-1604.
8. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
9. Byrnes, A. P., R. E. MacLaren, and H. M. Charlton. 1996. Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 16:3045-3055.
10. Byrnes, A. P., J. E. Rusby, M. J. Wood, and H. M. Charlton. 1995. Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66:1015-1024.
11. Byrnes, A. P., M. J. Wood, and H. M. Charlton. 1996. Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3:644-651.
12. Charneau, P., G. Mirambeau, P. Roux, S. Paulous, H. Buc, and F. Clavel. 1994. HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241:651-662.
13. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
14. Chiocca. E. A., B. B. Choi, W. Z. Cai, N. A. DeLuca, P. A. Schaffer, M. DiFiglia, X. O. Breakefield, and R. L. Martuza. 1990. Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants, New Biol. 2:739-746.
15. Coffin, J. M. 1990. Retroviridae: the viruses and their replication, p. 1437-1500. In B. N. Fields and D. M, Knipe (ed.). Virology. Raven, New York, N.Y.
16. Davidson, R. L., S. E. Doran, D. S. Shewach, J. M. Latta, J. W. Hurtman, and B. J. Roessler. 1994. Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp. Neurol. 125:258-267.
17. Engelhardt, J. F., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2A in recombimtnt adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91:6146-6200.
18. Esiri, M. M. 1982. Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J. Neurol. Sci. 54:209-226.
19. Ferrari, F. K., T. Samulski, T. Shenk, and R. J. Samulski. 1996. Secondstrand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70:3227-3234.
20. Friedman, B., S. Hockfield, J. A. Black, K. A. Woodruff, and S. G. Waxman. 1989. In situ demonstration of mature oligodendroeytes and their processes: an immunocytochcmical study with a new monoclonal antibody, rip. Glia 2:380-390.
21. Friedmann, T. 1994. Gene therapy for disorders of the CNS. Gene Ther. 1(Suppl. 1):S47-S48.
22. Friedmann, T. 1994. The promise und overpromise of human gene therapy Gene Ther. 1:217-218. (Editorial.)
23. Gallay. P., V. Stitt, C. Mundy, M. Oettinger, and D. Trono. 1996. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear im- port. J. Virol. 70:1027-1032.
24. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosinc phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
25. Gallay, P., S. Swingler, J, Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediaicd binding of matrix to the core domain of integrasc. Cell 83:569-576.
26. Gao, W. Y., A. Cara, R. C. Gallo, and F. Lori. 1993. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl. Acad. Sci. USA 90: 8925-8928.
27. Goodman, S., X. Xiao, R. E. Donahue, A. Moulton, J. Miller, C. Walsh, N. S. Young, R. J. Samulski, and A. W. Nienhuis. 1994. Recombinant adenoassociated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492-1500. (Erratum, 85:862, 1995.)
28. Halbert, C. L., I. E. Alexander, G. M. Wolgamot, and A. D. Miller. 1995. Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J. Virol. 69:1473-1479.
29. Huang, Q., J. P. Vonsattel, P. A. Schaffer, R. L. Martuza, X. O. Breakefield, and M. DiFiglia. 1992. Introduction of a foreign gene (Eseherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: a light and electron microscopic study. Exp. Neurol. 115:303-316.
30. Jolly, D. 1994. Viral vector systems for gene therapy. Cancer Gene Ther. 1:51-64.
31. Kaplitt, M. G., P. Leone, R. J. Sumulski, X. Xiao, D. W. Pfaff, K. L. O'Malley, and M. J. During. 1994. Long-term gene expression and phenotypic correction using adeno-associatcd virus vectors in the mammalian brain. Nat. Genet. 8:148-154.
32. Kuss-Eisler, A., E. Falck-Pedersen, D. H. Elfenbein, M. Alvira, P. M. Buttrick, and L. A. Leinwand. 1994. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:395-402.
33. Knowles, M. R., K. W. Hohneker, Z. Zhou, J. C. Olsen, T. L. Noah, P. C. Hu, M. W. Leigh, J. F. Engelhardt, L. J. Edwards, K. R, Jones, et al. 1995. A controlled study of adenoviral-veetor-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333:823-831.
34. Kotin, R. M., and K. I. Berns. 1989. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170:460-467.
35. Kuo, H., D. K. Ingram, R. G. Crystal, and A. Mastrangeli. 1995. Retrograde transfer of replication deficient recombinant adenovirus vector in the central nervous system for tracing studies. Brain Res. 705:31-38.
36. Leavitt, A. D., G, Robles, N. Alesandro. and H. E. Varmus. 1996. Human immunodeficiency virus type 1 integnise mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J. Virol. 70:721-728.
37. Lebkowski, J. S., M. M. McNally, T. B. Okarma, and L. B. Lerch. 1988. Adeno-associated virus: EI vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol. Cell. Biol. 8:3988-3996.
38. Leeds, J. M., and C. K, Mathews. 1987. Cell cycle-dependent effects on deoxyribonucleotide and DNA labeling by nueleoside precursors in mammalian cells. Mol. Cell. Biol. 7:532-534.
39. Leeds, J. M., M. B. Slabaugh, and C. K. Mathews. 1985. DNA precursor pools and ribonucleotide reductasc activity: distribution between the nucleus and cytoplasm of mammalian cells. Mol. Cell. Biol. 5:3443-3450.
40. Lewis, P., M. Hensel, and M. Emerman. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11:3053-3058. (Erratum. 11:4249.
41. Meyerhans, A., J. P. Vartanian, C. Hultgren. U. Plikat, A. Karlsson, L. Wang, S. Eriksson, and S. Wain-Hobson. 1994. Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J. Virol. 68:535-540.
42. Miller, A. D. 1990. Cell-surface receptor for retroviruses and implications for gene transfer. Proc. Natl. Acad. Sci. USA 93:11407-11413.
43. Miller, A. D., M.-F. Law, and I. M. Verma. 1985. Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate E resistant dihydrofolate reductase gene. Mol. Cell. Biol, 5:431-437.
44. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242. (Erratum. 12:433. 1992.)
45. Miller, J. L., R. E. Donahue, S. E. Sellers, R. J. Samulski, N. S. Young, and P A. W, Nienhuis. 1994. Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91:10183-10187. (Erratum. 92:646. 1995.)
46. Mullen, R. J., C. R. Buck, and A. M. Smith. 1992. NeuN. a neuronal specific nuclear protein in vertebrates. Development 116:201-211.
47. Mulligan, R. C. 1993. The basic science of gene therapy. Science 260: 926-932.
48. Muzyczka, N. 1992. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:97-129.
49. Naldlni, L., U. Blömer, P. Gaga, D. Trono. and I. M. Verma. 1996. Efficient transfer, integration and sustained long-term expression of the transgenc in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-1138.
50. Naldlini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
51. Naviaux, R. K., E. Costanzi, M. Haas, and I. M. Verma. 1996. The pCL vector system1, rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701-5705.
52. Palmer, T. D., G. J. Rosman, W. R. Osborne, and A. D. Miller. 1991. Genetically modified skin fibroblasts persist long term after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88: 1330-1334.
53. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
54. Peterson, D. A., C. A. Lucidi-Phillipi, K. L. Eagle, and F. H. Gage. 1994. Perforant path damage results in progressive neuronal death and somal atrophy in layer II of entorhinal cortex and functional impairment with increasing postdamage. J. Neurosci. 14:6872-6885.
55. Porter, C. D., M. K. Collins, C. S. Tailor, M. H. Parkar, F. L. Cosset, R. A. Weiss, and Y. Takeuchi. 1996. Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Hum. Gene Ther. 7:913-919.
56. Reddy, G. P., and R. S. Fager. 1993. Replicase: a complex integrating dNTP synthesis and DNA replication. Crit. Rev. Eukaryot. Gene Expr. 3:255-277.
57. Richardson, W. D., and H. Westphal. 1984. Requirement for either early region 1a or early region 1b adenovirus gene products in the helper effect for adeno-nssoeialed virus. J. Virol. 51:404-410.
58. Samulski. R. J., L. S. Chang, and T. Shenk. 1989. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63:3822-3828.
59. Scharfmann, R., J. H. Axelrodt, and I. M. Verma. 1991. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibrolast implants. Proc. Natl. Aead. Sci. USA 88:4620-4630.
60. Sterlo, D. C. 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc, 134:127-136.
61. St. Louis, D., and I. M. Verma. 1988. An alternative approach to somatic cell gene therapy. Proc. Natl, Acad. Sci. USA 85:3150-3154.
62. Trapnell, B. C., and M. Groziglia. 1994. Gene therapy using adenoviral vectors. Curr. Opin. Biotechnol. 5:617-625.
63. Verma, I. M. 1994. Gene therapy: hopes, hypes, and hurdles. Mol. Med. 1:2-3.
64. von Schwedler, U., R. S. Kornbluth, and D. Trono. 1994, The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad,.Sci. USA 91:6992-6996.
65. Wagner. R. R. 1987, Rhabdovirus biology and infection. An overview, p. 9-74. In R. R. Wagner (,cd.), The rhabdoviruses. Plenum Press, New York, N.Y.
66. West, M. H., J. P. Trempe, J. D. Tratschin, and B. J. Carter. 1987. Gene expression in adeno-associated virus vectors; the effects of chimeric mRNA structure, helper virus, and adenovirus VA1 RNA. Virology 160:38-47.
67. Wood, M. J., A. P. Byrnes, M. G. Kaplitt. U. W, Ptaff, S. D. Rabkin, and H. M. Charltun, 1994. Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting. Exp. Neurol. 130:127-140.
68. Yang, Y., F. A. Nunes, K. Berenesi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruscs improves the prospect for gene therapy in cystic tibrosis. Nat. Genet. 7:362-369.
69. Yoshide, M., and M. Seiki. 1990. In R. C. Gallo and F. Wong-Staal (ed.), Retrovirus biology and human disease. Dekker, New York, N.Y.
70. Zavada, J. 1972. Pseudotypes of vesicular stomatitis virus with the coat of murine leukaemia and of avian myeloblastosis viruses. J. Gen. Virol. 15:183-191.
71. Zhang, H., L. X. Duan, G.Dornadula, and R. J.Pomerantz. 1995. Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies. J. Virol. 69:3929-3932.